Assessment of primary skin irritation potential of Venusia cleanser: a human patch test study

Authors

  • Monil Gala Department of Medical Affairs, Dr. Reddy’s Laboratories Ltd., Hyderabad, Telangana, India https://orcid.org/0000-0002-9466-3301
  • Snehal Muchhala Department of Medical Affairs, Dr. Reddy’s Laboratories Ltd., Hyderabad, Telangana, India
  • Gauri Dhanaki Department of Medical Affairs, Dr. Reddy’s Laboratories Ltd., Hyderabad, Telangana, India
  • Arti Sanghavi Department of Medical Affairs, Dr. Reddy’s Laboratories Ltd., Hyderabad, Telangana, India
  • Bhavesh Kotak Department of Medical Affairs, Dr. Reddy’s Laboratories Ltd., Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20261096

Keywords:

Human patch test, Non-irritant cleanser, Sensitive skin dermal safety, Topical formulation

Abstract

Background: This study aimed to evaluate the skin irritation potential of Venusia Cleanser using a standardized human patch test, with particularly in individuals with sensitive skin.

Methods: A monocentric, single-blind, controlled study was conducted in accordance with IS 4011: 2018 Methods of Test for Safety Evaluation of Cosmetics (Third Revision) and ICH-GCP guidelines. Healthy adults aged 18–65 years were enrolled, with 50% having sensitive skin based on the lactic acid sting test. Venusia Cleanser (8% dilution), 0.9% saline (negative control), and 1% sodium lauryl sulfate (SLS, positive control) were applied on the upper back for 24 hrs using a patch test. Patches were applied at Visit 1 and removed after 24 hrs at Visit 2. Draize scoring was done at 48 hours, with a 1-week follow-up to confirm recovery.

Results: Of the 26 participants, 25 completed the study (mean age 31.6 years; 13 males, 12 females; 13 with sensitive skin). At 48 hours, Venusia Cleanser (8% dilution) demonstrated a mean irritation score of 1.12, well below the IS 4011:2018 threshold of 2.0, confirming its non-irritancy. The positive control (1% SLS) showed marked irritancy (mean score 3.04), while saline (mean score 0.00) produced no reaction. No delayed reactions occurred, and the formulation was well tolerated in both the sensitive and normal skin groups.

Conclusions: Venusia Cleanser was demonstrated to be safe, well-tolerated, and non-irritant for sensitive skin. These findings reinforce its suitability for daily-use cleansers, particularly for gentle cleansing that helps maintain skin barrier integrity while minimizing irritation risk.

References

Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063-72.

Sagrafena I, Morin M, Paraskevopoulos G, Nilsson EJ, Hrdinová I, Kováčik A, et al. Structure and function of skin barrier lipids: Effects of hydration and natural moisturizers in vitro. Biophys J. 2024;123(22):3951-63.

Mukhopadhyay P. Cleansers and their role in various dermatological disorders. Indian J dermatol. 2011;56(1):2-6.

Walters RM, Mao G, Gunn ET, Hornby S. Cleansing Formulations That Respect Skin Barrier Integrity. Dermatol Res Pract. 2012;2012:495917.

Ananthapadmanabhan KP, Moore DJ, Subramanyan K, Misra M, Meyer F. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatol Ther. 2004;17(1):16-25.

Mijaljica D, Townley JP, Klionsky DJ, Spada F, Lai M. The Origin, Intricate Nature, and Role of the Skin Surface ph (PHSS) in Barrier Integrity, Eczema, and Psoriasis. Cosmetics. 2025;12(1):24.

Mijaljica D, Spada F, Harrison IP. Skin Cleansing without or with Compromise: Soaps and Syndets. Molecules. 2022;27(6):2010.

Ananthapadmanabhan KP, Leyden JJ, Hawkins SS. Recent Advances in Mild and Moisturizing Cleansers. J Drugs Dermatol. 2019;18(1):s80-8.

Schachner LA, Alexis AF, Andriessen A, Berson D, Gold M, Goldberg DJ, et al. Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide-containing skincare. J Cosmet Dermatol. 2023;22(11):2902-9.

Sachdeva S. Fitzpatrick skin typing: Applications in dermatology. Indian J Dermatol Venereol Leprol. 2009;75(1):93-6.

Pandhi D, Inamadar AC, Saraswat A, De A, Parthasaradhi A, Chandrasekhar BS, et al. Spectrum of sensitive skin in India: a collaborative expert position statement. Front Med (Lausanne). 2025;12:1625172.

Kumar P, Paulose R. Patch Testing in Suspected Allergic Contact Dermatitis to Cosmetics. Dermatol Res Pract. 2014;2014:695387.

Vezakis IA, Lambrou GI, Kyritsi A, Tagka A, Chatziioannou A, Matsopoulos GK. Detecting Skin Reactions in Epicutaneous Patch Testing with Deep Learning: An Evaluation of Pre-Processing and Modality Performance. Bioengineering (Basel). 2023;10(8):924.

Overview:Allergic contact dermatitis. In: informedhealth.org. Institute for Quality and Efficiency in Health Care (IQWIG). 2024.

Lin SH, Chao YC. Clinical Characteristics and Patch Test Results in 57 Patients with Contact Dermatitis in Southern Taiwan. J Clin Med. 2025;14(7):2291.

Burkemper NM. Contact Dermatitis, Patch Testing, and Allergen Avoidance. Mo Med. 2015;112(4):296-300.

Mei-Hsia Chan M, Tan LS, Leow YH, Goon ATJ, Goh CL. Comparison of Irritancy Potential of Sodium Lauryl Sulfate-free Aqueous Cream to Other Moisturizers: An Intraindividual Skin Occlusive Study. J Clin Aesthet Dermatol. 2019;12(7):52-8.

Aramaki J, Löffler C, Kawana S, Effendy I, Happle R, Löffler H. Irritant patch testing with sodium lauryl sulphate: interrelation between concentration and exposure time. Br J Dermatol. 2001;145(5):704-8.

Hawkins SS, Subramanyan K, Liu D, Bryk M. Cleansing, moisturizing, and sun-protection regimens for normal skin, self-perceived sensitive skin, and dermatologist-assessed sensitive skin. Dermatol Ther. 2004;17(1):63-8.

Ghosh S, Blankschtein D. Why is sodium cocoyl isethionate (SCI) mild to the skin barrier? - An in vitro investigation based on the relative sizes of the SCI micelles and the skin aqueous pores. J Cosmet Sci. 2007;58(3):229-44.

Kurtz ES, Wallo W. Colloidal oatmeal: history, chemistry and clinical properties. J Drugs Dermatol. 2007;6(2):167-70.

Draelos ZD. A pilot study investigating the efficacy of botanical anti-inflammatory agents in an OTC eczema therapy. J Cosmet Dermatol. 2016;15(2):117-9.

Cho YS, Kim HO, Woo SM, Lee DH. Use of Dexpanthenol for Atopic Dermatitis—Benefits and Recommendations Based on Current Evidence. J Clini Med. 2022;11(14):3943.

Peltier E, Trapp S, De Salvo R, Sun C, Brandt M, Laing S, et al. A new dexpanthenol‐containing liquid cleanser for atopic‐prone skin: Results from two prospective clinical studies evaluating cutaneous tolerability, moisturization potential, and effects on barrier function. J Cosmet Dermatol. 2022;21(9):3859-66.

Chylińska N, Maciejczyk M. Hyaluronic Acid and Skin: Its Role in Aging and Wound-Healing Processes. Gels. 2025;11(4):281.

Wohlrab J, Kreft D. Niacinamide - mechanisms of action and its topical use in dermatology. Skin Pharmacol Physiol. 2014;27(6):311-5.

Rachmawati P, Kelvin A, Sidharta R, LIonita G, Kusuma IY. Optimization of Rosella Extract-based Antioxidant Peel-off Mask Using Simple Lattice Design. Turk J Pharm Sci. 2025;22(3):217-25.

Downloads

Published

2026-04-21

How to Cite

Gala, M., Muchhala, S., Dhanaki, G., Sanghavi, A., & Kotak, B. (2026). Assessment of primary skin irritation potential of Venusia cleanser: a human patch test study. International Journal of Research in Dermatology, 12(3), 205–210. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20261096

Issue

Section

Original Research Articles